| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4b7365de74045e8a7e0407f304451e1b |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 |
| filingDate |
2017-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88822544755f660b5e9e6ff10298ee59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a30b693c38ec606138dbe7cdba0d901
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5176db45b5cab83f66f27d82c828997
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cfc4e85dfad1fa5c9d2089419383fc11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf1ed20056d2268d28368cb65e21abea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29c477e77173c6022572d2e2e633d299
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1dafc3deacb445912fb6d570f1ea2b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_747c0a86645bd09e48beef7739694aaf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fd85c727e0f5b0bad03f59c03c60d1f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c3d139cb21af6c863a483c948113ec5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dad3bb9eef4de6345170aabff88e3fc1 |
| publicationDate |
2017-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20170081613-A |
| titleOfInvention |
Pharmaceutical composition comprising tonsil-derived mesenchymal stem cells for prevention or treatment of Inflammatory Bowel Disease |
| abstract |
The present invention relates to a composition for preventing or treating inflammatory bowel disease comprising Tonsil-derived mesenchymal stem cells (TMSC) as an active ingredient. The composition containing the one-shot derived mesenchymal stem cell (TMSC) of the present invention as an active ingredient reduces the expression of inflammatory factors and reduces the inflammation and disease activity due to inflammatory bowel disease. In particular, Prophylactic or therapeutic agents, and may be useful for the prevention or treatment of inflammatory bowel disease. |
| priorityDate |
2014-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |